ISDIN holds the IV Program for the Development of Managerial Capabilities (PDCD)
ISDIN, in collaboration with the IESE Business School of the University of Navarre, will hold the IV...
23/03/2010
ISDIN Participation in the 1st World Systemic Sclerosis Congress
During the 1st World Systemic Sclerosis ISDIN had the opportunity to reveal its research project on ...
15/03/2010
The FDA grants ISDIN the IND for the Disitertide project
During the past month of November the Food and Drug Administration (FDA) gave ISDIN its first IND (I...
20/11/2009
ISDIN opens its new subsidiary in Brazil
This is the third subsidiary of the company in the LATAM area, after Chile and Argentina....
20/06/2009
ISDIN opens its new subsidiary in Italy
In this manner the company continues its internationalization process, consolidating its presence in...
02/02/2009
ISDIN holds the second annual PDCD for young dermatologists
Experts in medicine, research and management instruct young physicians on the keys to boosting their...
05/06/2008
Initial evidence of the clinical efficacy of topical cyclosporine in the treatment of psoriasis
The study performed on patients with psoriasis has shown promising results in terms of the efficacy ...
30/05/2008
ISDIN consolidates its clinical research project in 2007
In recent years Isdin has decided to develop a solid clinical research project, which was consolidat...
07/01/2008
The World Health Organisation names the p144
The WHO (World Health Organisation) has provisionally assigned the name DISITERTIDE to our P144 pept...
07/01/2008
Knowledge: recent events & campaings
Event Location Date
Last 6 events See more